Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-14

Clinical Trial Update: Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating mass drug administration of ivermectin and dihydroartemisinin-piperaquine as an additional intervention for malaria elimination has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)
  • IVERMECTIN (Ivermectin)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 3 | Status: COMPLETED